| Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE … LQM Chow, R Haddad, S Gupta, A Mahipal, R Mehra, M Tahara, R Berger, ... Journal of Clinical Oncology 34 (32), 3838, 2016 | 848 | 2016 |
| Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe DU Kim, J Hayles, D Kim, V Wood, HO Park, M Won, HS Yoo, T Duhig, ... Nature biotechnology 28 (6), 617-623, 2010 | 773 | 2010 |
| Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial ME Gore, C Szczylik, C Porta, S Bracarda, GA Bjarnason, S Oudard, ... The lancet oncology 10 (8), 757-763, 2009 | 708 | 2009 |
| The transcriptional landscape and mutational profile of lung adenocarcinoma JS Seo, YS Ju, WC Lee, JY Shin, JK Lee, T Bleazard, J Lee, YJ Jung, ... Genome research 22 (11), 2109-2119, 2012 | 644 | 2012 |
| A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing YS Ju, WC Lee, JY Shin, S Lee, T Bleazard, JK Won, YT Kim, JI Kim, ... Genome research 22 (3), 436-445, 2012 | 604 | 2012 |
| An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection … S Kim, DH Lim, J Lee, WK Kang, JS MacDonald, CH Park, SH Park, ... International Journal of Radiation Oncology* Biology* Physics 63 (5), 1279-1285, 2005 | 443 | 2005 |
| Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1–positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study C Hsu, SH Lee, S Ejadi, C Even, RB Cohen, C Le Tourneau, JM Mehnert, ... Journal of Clinical Oncology 35 (36), 4050-4056, 2017 | 412 | 2017 |
| Carrier channel with element concentration gradient distribution and fabrication method thereof MC Lee, CK Tseng US Patent 9,196,483, 2015 | 406 | 2015 |
| Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas JK Lee, J Lee, S Kim, S Kim, J Youk, S Park, Y An, B Keam, DW Kim, ... Journal of clinical oncology 35 (26), 3065-3074, 2017 | 382 | 2017 |
| Co-composting of soybean residues and leaves in Hong Kong JWC Wong, KF Mak, NW Chan, A Lam, M Fang, LX Zhou, QT Wu, XD Liao Bioresource Technology 76 (2), 99-106, 2001 | 371 | 2001 |
| Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis B Keam, SA Im, KH Lee, SW Han, DY Oh, JH Kim, SH Lee, W Han, ... Breast Cancer Research 13, 1-7, 2011 | 297 | 2011 |
| Thermal annealing in hydrogen for 3-D profile transformation on silicon-on-insulator and sidewall roughness reduction MCM Lee, MC Wu Journal of Microelectromechanical systems 15 (2), 338-343, 2006 | 265 | 2006 |
| Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the … B Keam, SA Im, HJ Kim, DY Oh, JH Kim, SH Lee, EK Chie, W Han, ... BMC cancer 7, 1-11, 2007 | 249 | 2007 |
| Radiologic features of vasculitis involving the gastrointestinal tract HK Ha, SH Lee, SE Rha, JH Kim, JY Byun, HK Lim, JW Chung, JG Kim, ... Radiographics 20 (3), 779-794, 2000 | 247 | 2000 |
| Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer DY Kim, JH Kim, SH Lee, TY Kim, DS Heo, YJ Bang, NK Kim Annals of oncology 14 (3), 383-387, 2003 | 234 | 2003 |
| Mechanisms of acquired resistance to AZD9291: a mutation-selective, irreversible EGFR inhibitor TM Kim, A Song, DW Kim, S Kim, YO Ahn, B Keam, YK Jeon, SH Lee, ... Journal of Thoracic Oncology 10 (12), 1736-1744, 2015 | 227 | 2015 |
| Increased response rates to salvage chemotherapy administered after PD-1/PD-L1 inhibitors in patients with non–small cell lung cancer SE Park, SH Lee, JS Ahn, MJ Ahn, K Park, JM Sun Journal of Thoracic Oncology 13 (1), 106-111, 2018 | 217 | 2018 |
| Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial SH Lee, JK Lee, MJ Ahn, DW Kim, JM Sun, B Keam, TM Kim, DS Heo, ... Annals of Oncology 28 (2), 292-297, 2017 | 214 | 2017 |
| SARS in healthcare facilities, Toronto and Taiwan LC McDonald, AE Simor, IJ Su, S Maloney, M Ofner, KT Chen, JF Lando, ... Emerging infectious diseases 10 (5), 777, 2004 | 210 | 2004 |
| Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy J Lee, YH Park, WS Kim, SS Lee, BY Ryoo, SH Yang, KW Park, JH Kang, ... European Journal of Cancer 41 (10), 1402-1408, 2005 | 209 | 2005 |
